You are here: Industry Insights > Dengue

News List

Forensic Exam Shows Pattern in 4 Deaths of Sanofi Dengue Vaccine Recipients biospace
January 11, 2018
Forensic examination conducted on 4 children who received a controversial dengue vaccine indicated a "pattern" that led to their deaths, the Public Attorney's Office said Wednesday.
WHO advises Dengvaxia to be used only in people previously infected with dengue biospectrumasia
December 18, 2017
This recommendation is based on new evidence communicated by the vaccine’s manufacturer (Sanofi Pasteur), indicating an increase in incidence of hospitalization and severe illness in vaccinated children never infected with dengue
Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow biospace
December 01, 2017
Sanofi expects to take a nearly $120 million hit after a long-term study showed use of its dengue vaccine Dengvaxia could worsen the effects of the mosquito-borne illness in people who had previously not been exposed to the virus.
Novel assay detects Zika, differentiates from dengue and other flaviviruses pharmafile
July 20, 2017
A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an antibody-based assay which identify Zika infection, even differentiating it from other flaviviruses such as dengue.
Intent on vaccine growth, Takeda clinches massive enrollment goal in phase 3 dengue study pharmaasia
April 07, 2017
Less than seven months after kicking off its largest vaccine trial to date, Takeda has finished enrolling 20,100 children for a mammoth phase 3 dengue study in eight endemic countries.
Sanofi creates vaccine growth in 2016 despite lifeless Dengvaxia launch fiercepharma
February 09, 2017
In spite of trouble picking up steam with its first-of-a-kind dengue shot, Sanofi’s vaccines unit chipped in with 8.8% growth on the year, providing a boost for the company as other units failed to hold their ground.
Sanofi says Philippine FDA's demand to stop dengue ads comes as 'complete surprise' fiercepharma
January 06, 2017
Sanofi's promotional efforts for Dengvaxia have taken a hit in the Philippines.

Previous page 1 2 Next page